Evoke Wealth, LLC Incyte Corp Transaction History

Evoke Wealth, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$66.18 - $82.86 $3,309 - $4,143	-50 Reduced 20.0%	200 $13,000
Q2 2022 Aug 04, 2022	BUY	$66.18 - $83.18 $1,323 - $1,663	20 Added 8.7%	250 $19,000
Q1 2022 May 10, 2022	BUY	$66.02 - $79.71 $5,743 - $6,934	87 Added 60.84%	230 $18,000
Q2 2021 Aug 05, 2021	SELL	$79.87 - $87.53 $958 - $1,050	-12 Reduced 7.74%	143 $12,000
Q3 2020 Nov 13, 2020	SELL	$85.07 - $109.69 $19,481 - $25,119	-229 Reduced 59.64%	155 $14,000
Q2 2020 Aug 10, 2020	BUY	$74.18 - $108.93 $16,764 - $24,618	226 Added 143.04%	384 $40,000
Q1 2020 May 07, 2020	BUY	$63.18 - $85.97 $9,982 - $13,583	158 New	158 $11.6 Million
Q4 2019 Feb 07, 2020	SELL	$73.04 - $95.72 $15,192 - $19,909	-208 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$72.82 - $86.52 $15,146 - $17,996	208 New	208 $15.4 Million

642

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.